Contact Us  |  Site Map  |  Search  |  Client Login  
 
 
Boston Millennia Partners
   
  Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and life sciences industry. Our team brings over one hundred years of combined private equity experience to the investment process. Our broad experience, combined with expertise in finance; operations; engineering; life sciences research and development; partnering with pharmaceutical companies; business development; executive recruiting; and law provides significant value to the companies in which we invest. Since the early 1980’s, members of our team have managed seven venture capital partnerships with very successful results for our investors and our entrepreneurs. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our capital base to over $700 million under management.  
 

Boston Millennia Partners is pleased to announce that its portfolio company, CardioMEMS, Inc., an Atlanta based medical device company, has accepted a $60 million investment from and granted a $375 million purchase option to St. Jude Medical, Inc.

"The CardioMEMS CHAMPION Heart Failure System has demonstrated superb clinical, quality of life and cost reduction potential for CHF patients. St. Jude Medical is an excellent partner with whom this technology can be brought to market promptly, improving clinical prospects for patients and cost of care for payers." says Patrick Fortune PhD, a partner at Boston Millennia Partners and member of the CardioMEMS Board of Directors.

Read More >


 
   
   

MedAptus First Again in KLAS Mobile Data Systems Rankings
Boston Millennia portfolio company, MedAptus, was named first in KLAS Mobile Data Systems Rankings. MedAptus' top-ranking score in the "2011 Best in KLAS Awards: Software & Services" report is based on positive customer feedback for the second year in a row.

Learn More >

me2me AG and MedAptus Partner to Provide Advanced Mobile Charge Capture, Dictation and Workflow Solutions to Physician Groups
Boston Millennia portfolio company, MedAptus, has partnered with me2me AG, a software company delivering mobile dictation, transcription and speech recognition solutions.

Learn More >

Parexel International Releases 2011 Annual Report
Boston Millennia's Strategic Partner, Parexel International, released their 2011 Annual Report detailing favorable progress over the year.

Learn More >

Dana Callow Elected to National Board of Directors of the Leukemia & Lymphoma Society
Boston Millennia Partners Managing General Partner, Dana Callow, was elected to the Board of Directors of the Leukemia & Lymphoma Society. LLS is the largest voluntary health agency dedicated to blood cancer.

Learn More >

Millennia Portfolio Company, MedAptus®, Names Dr. Ryan Secan Chief Medical Officer
MedAptus®, the market leader for charge capture technologies, announced that Dr. Ryan A. Secan, has joined the company as Chief Medical Officer. Dr. Secan is currently a practicing hospitalist at Emerson Hospital in Concord, MA.

Learn More >

PAREXEL International Named Company Of The Year For The Pharmaceutical Industry
Boston Millennia Strategic Partner, PAREXEL International Corp., has been named Company of the Year for the Pharmaceutical Industry in The Eighth Annual International Business Awards.

Learn More >

CardioMEMS Founder & CEO Dr. Jay Yadav Named Ernst & Young Entrepreneur of the Year®
Boston Millennia Partners portfolio company, CardioMEMS, CEO & Founder, Dr. Jay Yadav was named Ernst & Young Entrepreneur of the Year in the health sciences catagory.

Learn More >

Odyssey Logistics & Technology Year-Over-Year Revenues Through May Up 93 Percent
Boston Millennia portfolio Company Odyssey Logistics & Technology has announced that top line revenues in 2011 grew 93 percent through May when compared with the same period a year ago.

Learn More >

Boston Millennia Strategic Partner PAREXEL signs agreement with Pfizer
Boston Millennia Strategic Partner, PAREXEL International Corp., has announced that it has been selected to become a strategic partner with Pfizer, Inc. to provide clinical development services.

Learn More >

CardioMEMS Founder & CEO Dr. Jay Yadav Named Ernst & Young Entrepreneur of the Year Finalist
Dr. Jay Yadav, founder and CEO of CardioMEMS, a Boston Millennia Partners portfolio company, was named Ernst & Young Entrepreneur of the Year Finalist. Dr. Yadav founded CardioMEMS to develop devices for the treatment of chronic cardiovascular diseases.

Learn More >

 
 
Click Here to receive news updates
from Boston Millennia Partners >



 
CEO Video Dana Callow on Bloomberg TV with Pimm Fox

Video: Click Here to View
CEO Video NECN CEO Corner Interview With Dana Callow

Video: Large | Small
CEO Video Dana Callow on PBS’s Greater Boston With Emily Rooney

Video: Large | Small
spacer
   
Healthcare information is becoming broadly available to consumers, which is expanding basic demand.
Learn More >
 
   
Three key areas of opportunity in the Life Sciences sector are drug discovery & development...
Learn More >
 
 
  | Our Firm      Our Team      Our Portfolio      Resources      News  
  © 2008 Boston Millennia Partners  All Rights Reserved